Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-28 @ 11:36 PM
Study NCT ID:
NCT04859868
Status:
COMPLETED
Last Update Posted:
2023-09-28
First Post:
2021-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Non-pharmaceutical Motion Sickness Mitigation
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
Non-pharmaceutical Motion Sickness Mitigation
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular Stimulation (GVR) amplitude on functional fitness task performance.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 80NSSC21K0175 | OTHER_GRANT | National Aeronautics and Space Administration | View |